Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep 22:10:280.
doi: 10.1186/1471-2334-10-280.

Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults

Affiliations

Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults

Herbert Longwe et al. BMC Infect Dis. .

Abstract

Background: Untreated human immunodeficiency virus (HIV) disease disrupts B cell populations causing reduced memory and reduced naïve resting B cells leading to increases in specific co-infections and impaired responses to vaccines. To what extent antiretroviral treatment reverses these changes in an African population is uncertain.

Methods: A cross-sectional study was performed. We recruited HIV-uninfected and HIV-infected Malawian adults both on and off antiretroviral therapy attending the Queen Elizabeth Central hospital in Malawi. Using flow cytometry, we enumerated B cells and characterized memory B cells and compared these measurements by the different recruitment groups.

Results: Overall 64 participants were recruited - 20 HIV uninfected (HIV-), 30 HIV infected ART naïve (HIV+N) and 14 HIV-infected ART treated (HIV+T). ART treatment had been taken for a median of 33 months (Range 12-60 months). Compared to HIV- the HIV+N adults had low absolute number of naïve resting B cells (111 vs. 180 cells/μl p = 0.008); reduced memory B cells (27 vs. 51 cells/μl p = 0.0008). The HIV+T adults had B-cell numbers similar to HIV- except for memory B cells that remained significantly lower (30 vs. 51 cells/μl p = 0.02). In the HIV+N group we did not find an association between CD4 count and B cell numbers.

Conclusions: HIV infected Malawian adults have abnormal B-cell numbers. Individuals treated with ART show a return to normal in B-cell numbers but a persistent deficit in the memory subset is noted. This has important implications for long term susceptibility to co-infections and should be evaluated further in a larger cohort study.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Absolute B cell counts from HIV negative, HIV positive ART naïve and on ART. Medians (10th and 90th percentiles) of absolute B cell counts (x103cells/ml) in HIV negative (n = 20), HIV infected subjects ART naïve (n = 30) and HIV infected subjects on ART (n = 14).
Figure 2
Figure 2
Scatter plots evaluating correlation between CD4 T cell and absolute B cell counts and between absolute B cell counts and total lymphocyte counts in both HIV+N and HIV+T. Scatter plots evaluating correlation between CD4 T cell counts and absolute B cell counts in HIV positive adults ART naïve (Figure 2a) and HIV positive adults on ART (Figure 2b). Correlation between absolute B cell counts and total lymphocyte counts in HIV positive adults ART naïve (Figure 2c) and HIV positive adults on ART (Figure 2d)

References

    1. French N, Moore M, Haikala R, Kayhty H, Gilks CF. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis. 2004;190(4):707–712. doi: 10.1086/421911. - DOI - PubMed
    1. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis. 2007;20(1):11–15. doi: 10.1097/QCO.0b013e328012c5f1. - DOI - PubMed
    1. French N, Gilks C. In: Manson's Tropical Diseases. 21. Cook GC, Zumla AI, editor. Elsevier; 2003. Pneumococcal Disease.
    1. Richard Y, Lefevre E, Krzysiek R. In: Cellular Aspects of HIV Infection. Cossarizza A, Kaplan D, editor. New York: Wiley InterScience; 2002. B cells in the line of sight of HIV-1; pp. 69–102.
    1. Townsley-Fuchs J, Neshat MS, Margolin DH, Braun J, Goodglick L. HIV-1 gp120: a novel viral B cell superantigen. Int Rev Immunol. 1997;14(4):325–338. - PubMed

Publication types

Substances